Join us for an insightful session featuring Gary Summers from GSK and Andrew Rainboldt from Intelligencia AI as they explore how cutting-edge causal inference techniques, applied to a decade of oncological clinical trial data, can revolutionize trial design and improve outcomes.
Key takeaways
- How causal inference evaluates the impact of clinical design decisions, with a focus on biomarkers and their role in clinical trial success.
- Why integrating high-quality data with advanced methodologies is critical for informed decision-making.
- Practical insights into applying causal inference to uncover hidden relationships and optimize trial design.
- The connection between biomarkers and the likelihood of technical and regulatory success.
